Trump, tariffs and US pharmaceutical industry
Digest more
Top News
Overview
Reactions and opinions
USA TODAY |
The U.S. depends on medicines partly produced in Europe that bring in hundreds of billions of dollars in revenue.
Reuters |
Trump announced 25% tariffs on car and auto parts on Wednesday, sending global automakers' shares down and raising fears of job losses in big auto-exporting countries.
Reuters |
"I don't think so," Trump told reporters at the White House, when asked if Americans should move up auto purchases.
Read more on News Digest
The ongoing investigation by Wyden and his Democratic compatriots from the Finance Committee has pointed the finger at multiple drugmakers in recent years, including Merck, which allegedly shifted profits on its megablockbuster Keytruda offshore to dodge billions of dollars in U.S. taxes.
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
Download our guide to the digital therapeutics landscape, key providers, and market trends. Discover how digital health solutions can enhance pharmaceutical outcomes.
The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.
Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are preparing for a potential TV pharma ad ban.
Too often, the disconnect between a company’s IT department and its business teams slows progress and leads to missed opportunities. In the fast-moving pharmaceutical industry, that can mean the difference between success and losing out to a rival.
Investment bankers say large pharma and biotech deals are stalling as executives grapple with mercurial White House economic policies
The Brevard-based doctor and former congressman said: "The concern of many people is that big Pharma was behind this, which is probably true."
3d
Worldcrunch on MSNIndia's Pharma Industry Is Not Immune To The Spread Of AIThe industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.